Pasireotide LAR in patients with metastatic carcinoid tumors: Interim safety results from a randomized, multicenter phase I study

被引：0
|
作者：
Wolin, E. [1 ]
Kvols, L. [2 ]
Ezzat, S. [3 ]
Kocha, W. [4 ]
Van Cutsern, E. [5 ]
Schonherr, U. [6 ]
Fandi, A. [7 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[3] Univ Toronto, Ontario Canc Inst, Toronto, ON M5S 1A1, Canada
[4] London Reg Canc Ctr, London, ON N6A 4L6, Canada
[5] Univ Hosp Gasthuisberg, Digest Oncol Unit, B-3000 Leuven, Belgium
[6] Novartis Pharma AG, Basel, Switzerland
[7] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：54 / 54
页数：1
相关论文
共 50 条
  • [41] INTERIM RESULTS OF A PHASE I/II STUDY OF BIWEEKLY PACLITAXEL AND CISPLATIN IN PATIENTS WITH METASTATIC BREAST-CANCER
    TOLCHER, AW
    GELMON, KA
    SEMINARS IN ONCOLOGY, 1995, 22 (04) : 28 - 32
  • [42] A multicenter phase I safety study of intratumoral photoactivation of talaporfin sodium in patients with refractory solid tumors
    Lustig, RA
    Vogl, TJ
    Fromm, D
    Cuenca, R
    Hsi, RA
    D'Cruz, AK
    Krajina, Z
    Turic, M
    Singhal, A
    Chen, JC
    CANCER, 2003, 98 (08) : 1767 - 1771
  • [43] Safety and efficacy of efpegerglucagon in patients with congenital hyperinsulinism: interim results from a phase 2 study
    Dastamani, Antonia
    Banerjee, Indraneel
    Mohnike, Klaus
    Puri, Mala
    Gwak, Eunji
    Kang, Seohyun
    Byeon, JinHee
    Lee, Moon Hee
    De Leon, Diva
    HORMONE RESEARCH IN PAEDIATRICS, 2024, 97 : 319 - 319
  • [44] Multicenter phase 2 study of nintedanib in patients (pts) with advanced progressing carcinoid tumors.
    Iyer, Renuka V.
    Konda, Bhavana
    Owen, Dwight Hall
    Attwood, Kristopher
    Sarker, Suman
    Suffren, Sheryl-Ann
    Wilton, John
    Bies, Robert
    Casucci, Danielle
    Reidy, Diane Lauren
    Shah, Manisha H.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Safety and preliminary activity of naptumomab estafenatox (NAP) and durvalumab in patients with advanced or metastatic solid tumors: interim results from a phase 1b trial
    Geva, Ravit
    Stemmer, Salomon
    Perets, Ruth
    Maurice-Dror, Corinne
    Ben-Ami, Eitan
    Raphael, Ari
    Kumar, Sanjeev
    Lorber, Ilana
    Kedem, Tal Hetzroni
    Fields, Scott Z.
    Rozencweig, Marcel
    Golan, Talia
    CANCER RESEARCH, 2023, 83 (08)
  • [46] Updated Results of a Phase I Study of Pasireotide (SOM230) in Combination with Everolimus in Patients (pts) with Advanced Neuroendocrine Tumors (NET)
    Chan, Jennifer A.
    Ryan, David P.
    Fuchs, Charles S.
    Zhu, Andrew X.
    Abrams, Thomas A.
    Wolpin, Brian M.
    Malinowski, Paige
    Regan, Eileen
    Kulke, Matthew H.
    PANCREAS, 2012, 41 (02) : 344 - 344
  • [47] Phase I dose-escalation study of long-acting pasireotide in patients with neuroendocrine tumors
    Yao, James C.
    Chan, Jennifer A.
    Mita, Alain C.
    Kundu, Madan G.
    Resendiz, Karina Hermosillo
    Hu, Ke
    Ravichandran, Shoba
    Strosberg, Jonathan R.
    Wolin, Edward M.
    ONCOTARGETS AND THERAPY, 2017, 10 : 3177 - 3186
  • [48] Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
    Oaknin, Ana
    Pothuri, Bhavana
    Gilbert, Lucy
    Sabatier, Renaud
    Brown, Jubilee
    Ghamande, Sharad
    Mathews, Cara
    O'Malley, David M.
    Kristeleit, Rebecca
    Boni, Valentina
    Gravina, Adriano
    Banerjee, Susana
    Miller, Rowan
    Pikiel, Joanna
    Mirza, Mansoor R.
    Dewal, Ninad
    Antony, Grace
    Dong, Yuping
    Zografos, Eleftherios
    Veneris, Jennifer
    Tinker, Anna V.
    CLINICAL CANCER RESEARCH, 2023, 29 (22) : 4564 - 4574
  • [49] Trastuzumab (T) combined with standard chemotherapy in HER plus metastatic bladder cancer (BC) patients: Interim safety results of a prospective randomized phase II study
    Beuzeboc, P.
    Banu, E.
    Voog, E.
    Bousquet, G.
    Priou, F.
    Deplanque, G.
    Bozec, L.
    Machiels, J. P.
    Vannetzel, J. M.
    Oudard, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [50] Long-term efficacy and safety of subcutaneous pasireotide in acromegaly: results from an open-ended, multicenter, Phase II extension study
    Petersenn, Stephan
    Farrall, Andrew J.
    Block, Christophe
    Melmed, Shlomo
    Schopohl, Jochen
    Caron, Philippe
    Cuneo, Ross
    Kleinberg, David
    Colao, Annamaria
    Ruffin, Matthieu
    Resendiz, Karina Hermosillo
    Hughes, Gareth
    Hu, Ke
    Barkan, Ariel
    PITUITARY, 2014, 17 (02) : 132 - 140
12345